Tau and Aβ42 protein in CSF of patients with frontotemporal degeneration

被引：3
|
作者：
Pijnenburg, YAL
Schoonenboom, NSNM
Scheltens, P
机构：
来源：
NEUROLOGY | 2003年 / 60卷 / 02期
关键词：
D O I：
10.1212/WNL.60.2.353-a
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [41] Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration
    Josephs, Keith A.
    Dickson, Dennis W.
    NEUROBIOLOGY OF AGING, 2007, 28 (11) : 1718 - 1722
  • [42] Review: Neuropathology of non-tau frontotemporal lobar degeneration
    Neumann, M.
    Mackenzie, I. R. A.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (01) : 19 - 40
  • [43] Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration
    Kapaki, Elisabeth
    Paraskevas, George P.
    Papageorgiou, Sokratis G.
    Bonakis, Anastasios
    Kalfakis, Nikolaos
    Zalonis, Ioannis
    Vassilopoulos, Demetris
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2008, 22 (01): : 47 - 53
  • [44] CSF Biomarkers for Alzheimer's Disease and Frontotemporal Lobar Degeneration
    Hu, William
    Chen-Plotkin, Alice
    Arnold, Steven
    Grossman, Murray
    Clark, Christopher
    Shaw, Les
    McCluskey, Leo
    El-Man, Lauren
    Karlawish, Jason
    Hurtig, Howard
    Siderowf, Andrew
    Soares, Holly
    Lee, Virginia
    Trojanowski, John
    NEUROLOGY, 2010, 74 (09) : A98 - A98
  • [45] Comparative single cell analysis in postmortem brains of patients with frontotemporal lobar degeneration with tau deposition
    Hargus, G.
    Al Dalahmah, O.
    Paryani, F.
    Jakubiak, K.
    DeTure, M.
    Dickson, D.
    Canoll, P.
    Goldman, J.
    Menon, V.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 512 - 512
  • [46] CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia
    Benussi, A.
    Archetti, S.
    Galimberti, D.
    Parnetti, L.
    Nacmias, B.
    Ferrari, F.
    Sorbi, S.
    Scarpini, E.
    Padovani, A.
    Borroni, B.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S4 - S5
  • [47] Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
    Borroni, Barbara
    Benussi, Alberto
    Archetti, Silvana
    Galimberti, Daniela
    Parnetti, Lucilla
    Nacmias, Benedetta
    Sorbi, Sandro
    Scarpini, Elio
    Padovani, Alessandro
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2015, 16 (1-2) : 86 - 91
  • [48] The CSF Aβ42, Tau and phosphorylated Tau as a predictive biomarker of Alzheimer's disease
    Herukka, SK
    Helisalmi, S
    Tervo, S
    Hallikainen, M
    Vanhanen, M
    Kejonen, K
    Soininen, H
    Pirttilä, T
    NEUROBIOLOGY OF AGING, 2004, 25 : S359 - S359
  • [49] CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
    Liu, Changqin
    Cholerton, Brenna
    Shi, Min
    Ginghina, Carmen
    Cain, Kevin C.
    Auinger, Peggy
    Zhang, Jing
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 271 - 276
  • [50] CSF Aβ42, tau and phosphorylated tau correlate with medial temporal lobe atrophy
    Herukka, Sanna-Kaisa
    Pennanen, Corina
    Soininen, Hilkka
    Pirttila, Tuula
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 14 (01) : 51 - 57
12345